Introduction
============

Severe radiation burns of the skin in most cases are often caused by human errors or accidents. However, up to 95% of patients undergoing radiation therapy get local radiation burns at varying intensities.[@b1-sccaa-11-069] The skin may react to varying degrees (erythema, edema, necrosis, and sclerosis) depending on the type of radiation, dose, and depth of penetration.[@b2-sccaa-11-069] Usually, severe radiation burns in a clinical setting are accidental. These burns are either because of overexposure as a result of time or faulty equipment and cause serious complications that require a longer recovery period. It should be noted that despite advances in the treatment methods (including surgical techniques), in case of severe radiation injuries to the skin, the clinical results are not satisfactory.[@b3-sccaa-11-069] To reduce the effects of radiation, the use of stem cells as a novel treatment has been suggested in scientific literature for a long period of time.[@b4-sccaa-11-069]--[@b9-sccaa-11-069] Many researchers believe that the clinical effects of stem cells in the treatment of acute and chronic trauma of internal organs are not related to the cells themselves, but the paracrine factors that are secreted by them in the intercellular space.[@b10-sccaa-11-069] As has been shown in previous experiments, paracrine factors secreted by cultured stem cells are effective in treating acute chemical and thermal burns of the skin and mucous membranes.[@b11-sccaa-11-069],[@b12-sccaa-11-069] Keeping in adherence to this, the aim of our experiment was to study the effect/impact of paracrine factors taken from stem cells from the bone marrow of rats in the treatment of local radiation burns.

The paracrine bioactive factors are produced by mesenchymal stem cells (MSCs) that deploy their task by paracrine factors as an essential mechanism, but their efficiency to regenerate still requires clarification. The demonstrations were executed on 16 male adult Wistar rats in radiation burn injury models. Once the experiment crossed 80 days of irradiation, the animals were removed and the ulceration was removed including healthy tissue. A morphometric evaluation was done with the samples to understand the maturity ratio of the granulating tissue. It was essential to assess the cell contents and so the thin inflamed necrotic membrane, middle, and innermost layers of the maturing granulating tissue and cells were evaluated. In the histological sections of the control animals, hyperplasia of the regenerating epidermis can be seen on the edge of the ulcer with symptoms of keratinization and acanthosis. The surface of the ulcer showed granulated tissue with abundant polymorphonuclear leukocytes (PMLs) and additional vessels with thickened and hyalinized walls. Their lumen also exhibited an accumulation of PML. Maturing fibrous tissue deep within the ulcer showed mild infiltration by lymphocytes. The histological sections obtained from the experimental group showed complete epidermization deep-seated in the ulcer. It was covered by a layer of maturing keratinized stratified squamous epithelium and mature fibrous tissue with slight diffusion of infiltration by lymphocytes. Morphometry table shows that the use of paracrine factors obtained from stem cells dramatically increases the maturation of granulated tissue in the bottom and the peripheral part of the wound. The MSC-based paracrine factors renew the process of reparative regeneration in intact tissues.

Materials and methods
=====================

All the experimental procedures were approved by the Committee of Animal Care, Department of Biotechnology, Moscow Institute of Physics and Technology, g. Dolgoprudnyy, Russia. The investigation conforms to the Guidelines for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No 85-23, revised 1985). The experiments were performed on 16 male adult rats belonging to the breed Wistar weighing between 235 and 315 g (M±m, 283.1±12.0 g experimental group and 283±8.6 g control group). The animals were kept in humane conditions including a standard diet and free access to drinking water. The living conditions and experimental procedures adhered to the general rules involved with experimental animals. The plan and execution of the experiment was approved and controlled by the Ethics Committee of the Institute. All manipulations to the animals were carried out after administering anesthesia (combination of Zoletil and Romitar). Rats were locally irradiated using the instillation ЛHК-268 (PAП 100-10) with a dose of 110 Gy at the rate of 21.4 Gy/min, voltage 30 kV, current 6.1 mA, filter 0.1 mm AI, and an exposure of 312 seconds. The rats were fixed on a specialized table on their abdomen (face down). The area of the irradiation field in the pre-iliac-lumbar region of the back was 8.2 and 8.5 cm^2^ and the fur from the region was removed.

Isolating stem cells from the bone marrow
-----------------------------------------

The MSCs were isolated from the bone marrow located in the hip bone under general anesthesia. The bone marrow mononuclear cell fraction was isolated by creating a density gradient using standard solution of lymphocyte-H (Cedarlane, Hornby, Ontario, Canada). After obtaining the suspension, the mononuclear cells were plated on to a Petri dish and cultured in DMEM and 10% FBS. To prove that the cells obtained had properties of MSC, they underwent osteocyte, chondrocyte, and adipocyte differentiation following standard protocol.[@b13-sccaa-11-069]

Obtaining peptides
------------------

After the cells had formed a monolayer, the medium was changed, and within 3 days the conditioned medium was collected. The conditioned medium was filtered using a filter with a diameter of 0.22 µm.

Scheme of administering the paracrine factors
---------------------------------------------

The peptides were administered in the form of an injection subcutaneously 0.5 mL (general protein 8 mg/mL) on the first, third, sixth, eighth, and tenth day after radiation.

Evaluating results
------------------

Photography, planimetry, and clinical assessment were carried out every week starting 15 days after radiation.

The area of skin damaged by radiation was calculated using the program DraftSight 20017x64. The severity of the pathological process was visually evaluated and assigned numerically ([Table 1](#t1-sccaa-11-069){ref-type="table"}).

Histology
---------

The animals were taken out of experiment 80 days after the irradiation. The ulcerative lesion was excised in its entirety along with healthy tissue and fixed with 10% buffered formalin. The measurement of the area and the grade of severity of the pathological process are presented in the tables and figures. Histological morphometry of the samples was conducted to assess the level of maturation in the granulating tissue. Prior to the analysis, the cell contents of the superficial (under the thin inflamed necrotic membrane), middle, and inner most layer of the maturing granulating tissue were evaluated.

The data were quantitatively analyzed with the help of Image Tool for Windows, v. 3.0 ("UTHSCSA", USA). After calibrating the normal distribution, the average arithmetic value (M) and the SD of the arithmetic mean (m) was calculated. Verification of the reliability in differences was based on student criterion (*t*). The mathematical calculations of quantitative data pertaining to histological preparations were performed using nonparametric statistics with a calculated median and interpercentile range. The comparison of the groups was undertaken with the help of multiple comparisons Kruskal--Wallis (packet of statistical programs Statistica-8; "StatSoft").

Results
=======

Both control and experimental groups were exposed to 110 Gy of X-rays, which resulted in the formation of localized radiation burns on the skin (*S*=6 cm^2^) 15 days later. Thirty days after radiation, the wound stabilized (surface of the wound was *S*=2.2±0.2 cm^2^) and fluctuated throughout the course of the pathological process.

As seen in [Figure 1A](#f1-sccaa-11-069){ref-type="fig"}, the wounded area on the skin from the 15th to the 29th day after radiation was practically the same in both groups. The wounded area gradually reduced by 6.1±0.4 cm^2^ (experimental group) and 5.9±0.6 cm^2^ (control group) 15 days after radiation up to 2.2±0.3 cm^2^ (in both control and experimental groups) on the 29th day after radiation. However, starting from the 36th day, there was a constant reduction in the burn area in the experimental group up to 0.2±0.1 cm^2^ till the 71st day after radiation. In the control group, the area of the lesion ranged from 1.4±0.6 cm^2^ on the 50th day to 1.9±0.8 cm^2^ on the 71st day. During the 57th to 71st day, the difference between the affected area in the experimental and control groups was 1:8.

Judging by clinical manifestations, the experimental group started showing significant differences from the control group 21 days after radiation ([Figure 1B](#f1-sccaa-11-069){ref-type="fig"}). Starting from the 36th day after radiation to the end of radiation, the difference between the clinical manifestations (represented as grades) in the control and experimental groups was statistically significant (*P*\<0.05). Visually the scabs in the experimental group of rats were thinner and superficial compared with the control group. On the 43rd day after irradiation, the pathological process in one of eight rats (12.5%) in the experimental group had terminated with the formation of an atrophied scar. On the 71st day in the experimental group, four rats (50%) had shown atrophied scars, and in the control group, only one (12.5%). Furthermore, during this time period five of eight rats in the control group exhibited deep and extensive ulcers ranging from 2 to 6 cm^2^, and in the experimental group, only two rats were left with light superficial scars with an area of 1.0 and 0.6 cm^2^.

According to clinical manifestations, the experimental groups already began to significantly differ from the control group by the 21st day ([Figure 1](#f1-sccaa-11-069){ref-type="fig"}). The scabs in the experimental group were visually thinner and superficial in comparison with the control group.

In the histological sections ([Figure 2](#f2-sccaa-11-069){ref-type="fig"}) of the control animals, hyperplasia of the regenerating epidermis can be seen on the edge of the ulcer with symptoms of keratinization and acanthosis. The surface of the ulcer showed granulated tissue with abundant PML and additional vessels with thickened and hyalinized walls. Their lumen also exhibited an accumulation of PML. Maturing fibrous tissue deep within the ulcer showed mild infiltration by lymphocytes.

The histological sections obtained from the experimental group showed complete epidermization deep seated in the ulcer. It was covered by a layer of maturing keratinized stratified squamous epithelium and mature fibrous tissue with slight diffusion of infiltration by lymphocytes.

The grading scale ([Table 2](#t2-sccaa-11-069){ref-type="table"}) of the histological results showed that the experimental group has a significantly higher level of regeneration with respect to skin-related wounds.

The experiment showed significant decrease in the level of leukocyte infiltration in the dermis of subcutaneous cells, thereby reducing necrosis.

Morphometry ([Table 3](#t3-sccaa-11-069){ref-type="table"}) shows that the use of paracrine factors obtained from steam cells dramatically increases the maturation of granulated tissue in the bottom and the peripheral part of the wound. This in turn renews the process of reparative regeneration in intact tissues.

Discussion
==========

The outcome of local radiation injuries of the skin (LRIS) is dependent on the radiation dose, area of injury, and the reaction of the organism itself. High doses of radiation cause the dysregulation of pro- and anti-inflammatory systems and as a rule, acute reactions turn to chronic inflammation.

Treating such chronic injuries requires surgical intervention with the excision of pathological tissues. This invasion shifts the process back to chronic inflammation, thereby ending the proliferative phase and overall repair of the tissue.

One of the possible causes for such a "chronic" process can be the dysfunction of regulatory cells (primarily immune cells), which are responsible for local inflammatory responses. If this theory holds true, then the addition of new and functionally active cells in the center of such lesions could potentially restore the regulation of local inflammatory responses.

Apparently, the properties of MSC include the selection of regulatory mediators and peptides, which further determines their effectiveness in the treatment of LRIS. It is to be expected that the paracrine function of MSCs is the basis of its clinical effect. This opinion is shared by most researchers using cells in the treatment of LRIS.[@b10-sccaa-11-069]

Majority of them have highlighted the anti-inflammatory and immunoregulatory effect tied with the mediators secreted by cells.[@b14-sccaa-11-069]

It must be mentioned that the use of functionally active autoregulatory cells leads to a pronounced clinical effect observed in not only radiation injuries but in most acute traumas.[@b15-sccaa-11-069]

The question still stands, which source of MSC should be used to safely and effectively treat acute radiation injuries.

If it was to be assumed that the prime time to transplant cells in the event of acute injuries is early (hours within the first day of exposure), then doctors simply will not be able to isolate and prepare the required quantity of cells from the bone marrow. An alternative can be the use of stromal vascular fraction (SVF). However, the feasibility of performing liposuction on patients with acute post-traumatic stress requires further research. Additionally, the isolation of the SVF can only be carried out at a hospital by an experienced professional.

The use of allogenic MSCs also has its limitations, like the risk of infections or the reactivation of viral infections.[@b16-sccaa-11-069] Next, the introduction of genetically alien material against a background of stress immunodeficiency can lead to the development of oncology.[@b17-sccaa-11-069]

Although human MSC-based bioactive factors are not clearly identified or determined, the therapeutic effects of stem cell transplantation depend on the production of paracrine bioactive factor. The strategy has been a promising cell-free therapeutic method for neovascularization in ischemic diseases.[@b18-sccaa-11-069] Stem cell-based paracrine factors promote cardiac repair and regeneration reviewed elsewhere.[@b19-sccaa-11-069] Further research is required to identify the specific paracrine factors that are more essential for regeneration of cell/tissue/organs.

The current aim of the study was to evaluate the viability of creating a medicinal product derived from MSCs containing paracrine factors. These factors in turn display anti-inflammatory and immunomodulatory effects. This medicinal product will enable the provision of first aid even outside clinics to reduce the degree of inflammation. This will further create conditions for conducting a full-scale cell therapy using autologous stem cells.

Our research has shown that animals subjected to very high doses of radiation (110 Gy) develop an acute inflammatory response. A fixed reduction in the area throughout the process of injury was not observed upon the use of paracrine factors from stem cells. This most likely indicates that these factors do not have a protective effect and they cannot save the cells from permanent damage. However, during the autopsy, it was noted that none of the animals in the experimental group had cicatricial adhesions. The damage was limited to the dermal layer. In the control group, inflammation besides the skin had spread to the fascia, muscular layer of the abdominal wall, and occasionally, in the loops of the intestine. It would seem that our product reduces inflammation at the alteration stage and aids in the correct exchange of inflammatory phases.

The obtained results help us evaluate the medicinal product, the paracrine factors it contains, and future perspectives in creating novel medicinal products for treating LSIR.
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![Dynamics of healing acute radiation injury in rats.\
**Notes: (A)** Area of injury; **(B)** severity of clinical process. Severity of the pathological process in the rats was evaluated using a grading scale ([Figure 1B](#f1-sccaa-11-069){ref-type="fig"}).](sccaa-11-069Fig1){#f1-sccaa-11-069}

![Zone of lesion on the 71st day.\
**Notes:** Dyed with H&E stain. Magnification of 200× **(A)** and 100× **(B)**.](sccaa-11-069Fig2){#f2-sccaa-11-069}

###### 

Grading scale assessing the skin's reaction to a radiation dose of 110 Gy

  Phase of damage up tô40 days                              Grade   Phase of recovery
  --------------------------------------------------------- ------- -----------------------------------------
  No observable changes                                     0       Atrophic scarring
  Hyperemia (+/−), impaired fur growth                      0.15    
  Hyperemia (+/−), hyperpigmentation, peeling               0.25    
  Hyperemia, hyperpigmentation                              0.5     Scarring, light crust
  Dry dermatitis                                            1       Scarring, crust on \~10%--20%
  Moist dermatitis                                          1.5     Scarring, crust on \~30%--50%
  Thin dry scab                                             2       Scarring, flat scab
  Dense dry scab                                            2.5     Dense scab in an area \<70%
  Dense scab, serous exudates                               3       Dense scabs in an area \<50%
  Flat dry scab                                             3.5     
  Flat dry scab, serous exudates                            4       Thin, fibrin, serous exudates
  Rough, heterogeneous scab, tightly adhered, superficial   4.5     Thin superficial membrane, moist, blood
  Rough heterogeneous scab, superficial serous exudate      5       Deep wound, thin and flat scab
  Rough, dense dry scab, deep                               5.5     Dense dry, deep
  Rough, deep scab, purulent exudate or blood               6       

###### 

Quantitative grading of the level of inflammatory responses (80 days after exposure)

                                                                                                                                                    Control   Peptides
  -------------------------------------------------------- ----------------------------- --------------------------------------------------- ------ --------- --------------------------------------------------
  Epidermis                                                Thickening of the epidermis   Absent                                              3      0.75      1.75
                                                           Weak                          2                                                                    
                                                           Moderate                      1                                                                    
                                                           Significant                   0                                                                    
  Stratification of keratinocytes                          Preserved                     1                                                   0      0.75      
                                                           Impaired                      0                                                                    
  Necrosis of the epidermis                                Absent                        1                                                   0      0.5       
                                                           Present                       0                                                                    
  Dermis                                                   Infiltration by leukocytes    Absent                                              3      0         2.75[a](#tfn1-sccaa-11-069){ref-type="table-fn"}
  Weak                                                     2                                                                                                  
  Moderate                                                 1                                                                                                  
  Significant                                              0                                                                                                  
  Necrosis of the dermis                                   Absent                        1                                                   0      0.75      
  Present                                                  0                                                                                                  
  Subcutaneous fat                                         Infiltration by leukocytes    Absent                                              3      0         2.75[a](#tfn1-sccaa-11-069){ref-type="table-fn"}
  Weak                                                     2                                                                                                  
  Moderate                                                 1                                                                                                  
  Significant                                              0                                                                                                  
  Necrosis of subcutaneous tissue and surrounding tissue   Absent                        1                                                   0.25   1.0       
  Present                                                  0                                                                                                  
  Regeneration                                             Absent                        1                                                   0.25   1.0       
  Present                                                  0                                                                                                  
  SUM Σ                                                    1.25                          11.25[a](#tfn1-sccaa-11-069){ref-type="table-fn"}                    

**Notes:**

*P*\<0.05 with respect to the control.

###### 

Morphometry of the cell population in the skin wound (80 days after exposure)

  Specimen     Quantity   Deep layer of the granulated tissues   Middle layer of the granulated tissues   Superficial layer of the granulated tissues   Mean    Fibroblast/cells
  ------------ ---------- -------------------------------------- ---------------------------------------- --------------------------------------------- ------- ------------------
  Control 1    Cells      606                                    444                                      284                                           444.7   0.47
  Fibroblast   195        216                                    213                                      208                                                   
  Control 2    Cells      504                                    316                                      316                                           378.6   0.48
  Fibroblast   166        178                                    197                                      180.1                                                 
  Control 3    Cells      647                                    378                                      152                                           392.6   0.42
  Fibroblast   181        198                                    113                                      164                                                   
  Control 4    Cells      518                                    321                                      248                                           362.4   0.40
  Fibroblast   122        147                                    166                                      144.8                                                 
  Peptides 1   Cells      109                                    121                                      Superficial epithelialization                 114.8   0.71
  Fibroblast   74         88                                     81                                                                                             
  Peptides 2   Cells      123                                    92                                       Superficial epithelialization                 107.3   0.65
  Fibroblast   78         62                                     70.2                                                                                           
  Peptides 3   Cells      290                                    102                                      102                                           164.8   0.43
  Fibroblast   96         41                                     75                                       70.8                                                  
  Peptides 4   Cells      136                                    131                                      Superficial epithelialization                 133.2   0.67
  Fibroblast   91         87                                     89.2                                                                                           
  Peptides 5   Cells      140                                    177                                      Superficial epithelialization                 158.7   0.50
  Fibroblast   75         82                                     78.7                                                                                           
